GRI Bio GRI
NASDAQ GRI
$1.47 +0.01 (+0.68%)
At close: Oct 21, 2026 · 4:00 PM EDT

GRI Bio (GRI) Current Leases (2020 - 2021)

Updated

GRI Bio (GRI) recorded Current Leases of $95,000 in Q1 2021, down 9.5% from the prior quarter.

Analysis

GRI Bio (GRI) Current Leases (2020 - 2021) Analysis & Trends

At the end of FY2020, GRI Bio reported Current Leases of $105,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 GRI Bio 2.65 Mn -31.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 95,000.00
Dec 31, 2020 105,000.00
API Access

GRI Bio Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=GRI&period=max&api_key=YOUR_API_KEY